Magnetic resonance angiography of lower-extremity arterial disease

Omaida C Velazquez, R. A. Baum, J. P. Carpenter

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Improvements in vascular technique have expanded the treatment options for patients with severe occlusive peripheral vascular disease. The decision to perform a major revascularization procedure in patients who are often at high risk for cardiovascular morbidity and mortality depends on the risk- benefit ratio. Detailed and accurate vascular imaging is essential in evaluating the likelihood of a successful revascularization with subsequent limb salvage. Although contrast angiography has been the time-honored reference standard imaging technique, the method is an invasive procedure with limitations and risks. MRA is a new, noninvasive vascular imaging technique that may now be added to the imaging options with the potential for improved sensitivity for finding patent runoff vessels, avoidance of morbidity, and cost equivalent to that of conventional contrast angiography. Magnetic resonance angiography is a rapidly developing and exciting new vascular imaging technique. As with any new technique, it is imperative that individual centers validate their MRA results and interpretations against the time-honored standard, which continues to be contrast arteriography. Several studies now indicate that MRA can be a cost-effective outpatient imaging technique sufficient for planning and successfully performing peripheral bypass procedures. As developments in hardware, software, and non- nephrotoxic contrast agents continue to increase, applicability of MRA in vascular surgery will continue to expand. Predictably, MRA will have a major role in the future of vascular imaging, and it is likely to supplant the need for conventional contrast angiography in the majority of patients.

Original languageEnglish
Pages (from-to)519-537
Number of pages19
JournalSurgical Clinics of North America
Volume78
Issue number4
StatePublished - Sep 5 1998
Externally publishedYes

Fingerprint

Magnetic Resonance Angiography
Blood Vessels
Lower Extremity
Angiography
Planning Techniques
Morbidity
Costs and Cost Analysis
Limb Salvage
Peripheral Vascular Diseases
Contrast Media
Outpatients
Software
Odds Ratio
Mortality

ASJC Scopus subject areas

  • Surgery

Cite this

Magnetic resonance angiography of lower-extremity arterial disease. / Velazquez, Omaida C; Baum, R. A.; Carpenter, J. P.

In: Surgical Clinics of North America, Vol. 78, No. 4, 05.09.1998, p. 519-537.

Research output: Contribution to journalArticle

Velazquez, Omaida C ; Baum, R. A. ; Carpenter, J. P. / Magnetic resonance angiography of lower-extremity arterial disease. In: Surgical Clinics of North America. 1998 ; Vol. 78, No. 4. pp. 519-537.
@article{c32631f86301457d8c4cefc2cdeaddb8,
title = "Magnetic resonance angiography of lower-extremity arterial disease",
abstract = "Improvements in vascular technique have expanded the treatment options for patients with severe occlusive peripheral vascular disease. The decision to perform a major revascularization procedure in patients who are often at high risk for cardiovascular morbidity and mortality depends on the risk- benefit ratio. Detailed and accurate vascular imaging is essential in evaluating the likelihood of a successful revascularization with subsequent limb salvage. Although contrast angiography has been the time-honored reference standard imaging technique, the method is an invasive procedure with limitations and risks. MRA is a new, noninvasive vascular imaging technique that may now be added to the imaging options with the potential for improved sensitivity for finding patent runoff vessels, avoidance of morbidity, and cost equivalent to that of conventional contrast angiography. Magnetic resonance angiography is a rapidly developing and exciting new vascular imaging technique. As with any new technique, it is imperative that individual centers validate their MRA results and interpretations against the time-honored standard, which continues to be contrast arteriography. Several studies now indicate that MRA can be a cost-effective outpatient imaging technique sufficient for planning and successfully performing peripheral bypass procedures. As developments in hardware, software, and non- nephrotoxic contrast agents continue to increase, applicability of MRA in vascular surgery will continue to expand. Predictably, MRA will have a major role in the future of vascular imaging, and it is likely to supplant the need for conventional contrast angiography in the majority of patients.",
author = "Velazquez, {Omaida C} and Baum, {R. A.} and Carpenter, {J. P.}",
year = "1998",
month = "9",
day = "5",
language = "English",
volume = "78",
pages = "519--537",
journal = "Surgical Clinics of North America",
issn = "0039-6109",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Magnetic resonance angiography of lower-extremity arterial disease

AU - Velazquez, Omaida C

AU - Baum, R. A.

AU - Carpenter, J. P.

PY - 1998/9/5

Y1 - 1998/9/5

N2 - Improvements in vascular technique have expanded the treatment options for patients with severe occlusive peripheral vascular disease. The decision to perform a major revascularization procedure in patients who are often at high risk for cardiovascular morbidity and mortality depends on the risk- benefit ratio. Detailed and accurate vascular imaging is essential in evaluating the likelihood of a successful revascularization with subsequent limb salvage. Although contrast angiography has been the time-honored reference standard imaging technique, the method is an invasive procedure with limitations and risks. MRA is a new, noninvasive vascular imaging technique that may now be added to the imaging options with the potential for improved sensitivity for finding patent runoff vessels, avoidance of morbidity, and cost equivalent to that of conventional contrast angiography. Magnetic resonance angiography is a rapidly developing and exciting new vascular imaging technique. As with any new technique, it is imperative that individual centers validate their MRA results and interpretations against the time-honored standard, which continues to be contrast arteriography. Several studies now indicate that MRA can be a cost-effective outpatient imaging technique sufficient for planning and successfully performing peripheral bypass procedures. As developments in hardware, software, and non- nephrotoxic contrast agents continue to increase, applicability of MRA in vascular surgery will continue to expand. Predictably, MRA will have a major role in the future of vascular imaging, and it is likely to supplant the need for conventional contrast angiography in the majority of patients.

AB - Improvements in vascular technique have expanded the treatment options for patients with severe occlusive peripheral vascular disease. The decision to perform a major revascularization procedure in patients who are often at high risk for cardiovascular morbidity and mortality depends on the risk- benefit ratio. Detailed and accurate vascular imaging is essential in evaluating the likelihood of a successful revascularization with subsequent limb salvage. Although contrast angiography has been the time-honored reference standard imaging technique, the method is an invasive procedure with limitations and risks. MRA is a new, noninvasive vascular imaging technique that may now be added to the imaging options with the potential for improved sensitivity for finding patent runoff vessels, avoidance of morbidity, and cost equivalent to that of conventional contrast angiography. Magnetic resonance angiography is a rapidly developing and exciting new vascular imaging technique. As with any new technique, it is imperative that individual centers validate their MRA results and interpretations against the time-honored standard, which continues to be contrast arteriography. Several studies now indicate that MRA can be a cost-effective outpatient imaging technique sufficient for planning and successfully performing peripheral bypass procedures. As developments in hardware, software, and non- nephrotoxic contrast agents continue to increase, applicability of MRA in vascular surgery will continue to expand. Predictably, MRA will have a major role in the future of vascular imaging, and it is likely to supplant the need for conventional contrast angiography in the majority of patients.

UR - http://www.scopus.com/inward/record.url?scp=0031873828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031873828&partnerID=8YFLogxK

M3 - Article

C2 - 9728199

AN - SCOPUS:0031873828

VL - 78

SP - 519

EP - 537

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

SN - 0039-6109

IS - 4

ER -